VASCULAR ACCESS DEVICE NON-ADHERING MEMBRANES

• US 20080027410A1
• Filed: 07/26/2007
• Published: 01/31/2008
• Est. Priority Date: 07/28/2006
• Status: Abandoned Application

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Guo, Lantao, McKinnon, Austin Jason, Harding, Weston F., Ou-Yang, David
• Application Number:
  US11/829,013
• Publication Number:
  US 20080027410A1
• Time in Patent Office: Days
• US Class Current: 604/507
• CPC Class Codes: A61M 2039/1072 with a septum present in the connector
• CPC Class Codes: A61M 39/045 pre-slit to be pierced by blunt instrument
• CPC Class Codes: A61M 39/16 having provision for disinfection or sterilisation A61M39/143 takes precedence; methods or apparatus for disinfection or sterilisation A61L2/00
• CPC Class Codes: A61M 39/162 with antiseptic agent incorporated within the connector
• CPC Class Codes: A61M 39/26 Valves closing automatically on disconnecting the line and opening on reconnection thereof check valves A61M39/24

Abstract

A medical device may include a vascular access device having a body and a membrane of the body. The membrane communicates with a pathogenic environment and discourages adhesion of a pathogen to the membrane. A method of discouraging a pathogen from residing on the membrane of a vascular access device includes providing a vascular access device with a body having a membrane and discouraging a pathogen from residing on the membrane.

Claims

1. A medical device, comprising:

a vascular access device including a body and a membrane of the body,

wherein the membrane communicates with a pathogenic environment, and

wherein the membrane discourages biofilm formation.

2. The medical device of claim 1, wherein the membrane includes pores, wherein the vascular access device includes an antimicrobial fluid, and wherein the antimicrobial agent is transferred across the membrane through the pores.

3. The medical device of claim 2, wherein the pores of the membrane are canals.

4. The medical device of claim 3, wherein the vascular access device further includes a reservoir, and wherein the antimicrobial agent is housed within the reservoir.

5. The medical device of claim 2, wherein the antimicrobial agent is transferred as the vascular access device is accessed by a separate device.

6. The medical device of claim 1, further comprising a vacuum source in communication with the membrane, wherein the membrane includes at least one pore, and wherein the vacuum source pulls the pathogen into one or more of the at least one pore.

7. The medical device of claim 6, wherein the membrane shears the pathogen as it is pulled into one or more of the at least one pore.

8. The medical device of claim 1, wherein the membrane includes pores, wherein the vascular access device includes a lubricant, and wherein the lubricant is transferred across the membrane through the pores.

9. The medical device of claim 1, wherein the membrane includes pores, wherein each pore houses a biocompatible gas bubble, and wherein the pores are separated by a minimal surface area of the membrane.

10. The medical device of claim 9, wherein the surface area between two pores of the membrane is less than the attaching surface area of a pathogen.

11. The medical device of claim 10, wherein the width of the each of the pores is at least twice the diameter of a pathogen.

12. A method of discouraging a pathogen from residing on the membrane of a vascular access device, comprising:

providing a vascular access device with a body, wherein the body includes a membrane at a location of the body that is in communication with a pathogenic environment, and

discouraging a pathogen from residing on the membrane of the vascular access device.

13. The method of claim 12, wherein discouraging includes transferring an antimicrobial agent across the membrane.

14. The method of claim 12, wherein discouraging includes pulling the pathogen across the membrane.

15. The method of claim 12, wherein discouraging includes shearing the pathogen.

16. The method of claim 12, wherein discouraging includes transferring a lubricant across the membrane.

17. The method of claim 12, wherein discouraging includes coating the membrane with biocompatible gas bubbles.

18. A medical device, comprising:

means for accessing the vascular system of a patient, and

means for discouraging biofilm formation on the medical device,

wherein the pathogen resides near the means for accessing the vascular system of a patient,

wherein the means for accessing the vascular system includes a body, and

wherein the means for discouraging biofilm formation includes a membrane of the body of the means for accessing the vascular system of a patient.

19. The medical device of claim 18, wherein the membrane repels the pathogen.

20. The medical device of claim 18, wherein the membrane attracts the pathogen.